Joint Formulary & PAD

Acetazolamide - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Initiation and stabilisation by the specialist team before transfer of prescribing to primary care.
 

Status 2

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Acetazolamide
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.